The latest therapeutic guidelines have incorporated all these features [13]–[18]•••, and ACE inhibitors are considered to be an important component of the polypill proposed as a means of reducing cardiovascular disease by 80% [19]. The gene discussed is ACE; the disease is cardiovascular disorder.